<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    SCYNEXIS, Inc.

    SCYNEXIS, Inc.

    SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the li...

    SCYNEXIS, Inc. is a biotechnology company commi...

    Filing Type:    PU
    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...

    NeuBase Therapeutics, Inc. is developing its mo...

    Filing Type:    PU
    KS Fitness LLC

    KS Fitness LLC

    KS Fitness is a game-changing fitness studio located in Hudson, NY. In a few short...

    KS Fitness is a game-changing fitness studio lo...

    Amount Raised:    $22,300.00
    Fundraising Status:    EC
    Filing Type:    CF
    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company th...

    Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a ...

    Filing Type:    PU
    Verona Pharma plc

    Verona Pharma plc

    Verona Pharma plc is a clinical stage biopharmaceutical company focused on the dev...

    Verona Pharma plc is a clinical stage biopharma...

    Filing Type:    PU
    Mylan N.V.

    Mylan N.V.

    Mylan is a global pharmaceutical company committed to setting new standards in hea...

    Mylan is a global pharmaceutical company commit...

    Filing Type:    PU
    NovoCure Limited

    NovoCure Limited

    Novocure is a global oncology company working to extend survival in some of the mo...

    Novocure is a global oncology company working t...

    Filing Type:    PU
    Progenics Pharmaceuticals Inc.

    Progenics Pharmaceuticals Inc.

    Progenics develops innovative medicines and other technologies to target and treat...

    Progenics develops innovative medicines and oth...

    Filing Type:    PU
    Inovio Pharmaceuticals, Inc.

    Inovio Pharmaceuticals, Inc.

    Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of trea...

    Inovio is bringing IMMUNO-INGENUITY™ to life ...

    Filing Type:    PU
    Equillium, Inc.

    Equillium, Inc.

    Equillium is a biotechnology company leveraging deep understanding of immunobiolog...

    Equillium is a biotechnology company leveraging...

    Filing Type:    PU
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    Immunic, Inc.

    Immunic, Inc.

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company develop...

    Immunic, Inc. (Nasdaq: IMUX) is a clinical-stag...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.